TADALAFIL PAH OrPha cpr pell 20 mg 56 cpr pell

7680679680012 CH-67968 G04BE08 02.07.1.

Active substances:

TADALAFIL PAH OrPha cpr pell 20 mg 56 cpr pell
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6796801
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
tadalafilum 20 mg, lactosum 312.5 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.8 mg, E 171, triacetinum, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 1.91 mg.

Articles (1)

Tadalafil PAH OrPha 20 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/02/2026
Patient information leaflet
Français
27/02/2026
Patient information leaflet
Italien
27/02/2026
Professional SmPC
Allemand
03/01/2024
Professional SmPC
Français
03/01/2024
Professional SmPC
Italien
03/01/2024

Detailed composition

Substance Quantity Type Category
tadalafilum
20.0 MG Substance Wirkstoff (Principe actif)
lactosum
312.5 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
hydroxypropylcellulosum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
lactosum monohydricum
2.8 MG Substance HBESI
E 171
- Substance FNIDK
triacetinum
- Substance HNIDK
talcum
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
natrium
1.91 MG Substance HBESI

Reimbursement information

Public price
CHF 406.15
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2021

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
67968
Drug name
Tadalafil PAH OrPha, Filmtabletten
Galenic form
FILM
ATC Code
G04BE08
Authorization status
Z
Dispensation category
B
First authorization
23/07/2020
Authorization expiration date
31/12/9999
IT number
02.07.1.
Domain
Human medicine
Field of application
Pulmonale arterielle Hypertonie

Packaging details

Description (FR)
TADALAFIL PAH OrPha cpr pell 20 mg 56 cpr pell
Description (DE)
TADALAFIL PAH OrPha Filmtabl 20 mg 56 Filmtabl
Market launch
23/07/2020
Narcotic (BTM)
No

Original drug

Adcirca, comprimés pelliculés
CHF 471.05
View original
Buy us a coffee Explore the data